Santiago-Vazquez Cristina, Palacios-Paino Nuria, Cordido Fernando
Servicio Endocrinología y Nutrición, Hospital Universitario A Coruña, 15006 A Coruña, Spain.
Grupo Fisiopatoloxía Endócrina, Nutricional e Médica (FENM), Facultad de Ciencias de la Salud, Universidade da Coruña, 15006 A Coruña, Spain.
Clin Pract. 2024 Jul 4;14(4):1310-1318. doi: 10.3390/clinpract14040106.
Pituitary adenomas (PAs) are the third most common brain tumors in adults right after meningiomas and gliomas. Taking into account their hormonal activity in vivo, they can be divided in functioning PAs, which secrete hormones, and nonfunctioning pituitary adenomas (NFPAs), which are not associated with increased hormone secretion. We present the case of a man diagnosed with pituitary apoplexy. A transsphenoidal surgery was performed with subtotal removal of the mass. Pituitary hormones were measured before and after the procedure on several occasions, showing always normal PRL values, so he was diagnosed with a clinically NFPA. Two years later, the patient noticed a visual deficit. A new magnetic resonance imaging study was performed, showing adenomatous recurrence, and the patient underwent a new surgery. After this, hormonal evaluation revealed high levels of PRL on several occasions. After treatment with cabergoline was started, PRL levels normalized, the visual deficit improved, and there was a slight adenoma reduction. This case report represents an exception to the paradigm that in the presence of a macroadenoma and normal PRL levels (avoiding the "hook effect"), a prolactinoma can be discarded. Moreover, it stresses the importance of comprehensive, regular, and lifelong surveillance of patients with NFPAs and the close monitoring of serum PRL.
垂体腺瘤(PAs)是成人中第三常见的脑肿瘤,仅次于脑膜瘤和神经胶质瘤。考虑到它们在体内的激素活性,可分为分泌激素的功能性垂体腺瘤和与激素分泌增加无关的无功能性垂体腺瘤(NFPA)。我们报告一例诊断为垂体卒中的男性病例。进行了经蝶窦手术,次全切除肿块。在手术前后多次测量垂体激素,催乳素(PRL)值始终正常,因此他被诊断为临床无功能性垂体腺瘤。两年后,患者出现视力障碍。进行了一项新的磁共振成像检查,显示腺瘤复发,患者接受了再次手术。此后,激素评估多次显示PRL水平升高。开始使用卡麦角林治疗后,PRL水平恢复正常,视力障碍改善,腺瘤略有缩小。本病例报告是一个例外,即存在大腺瘤且PRL水平正常(避免“钩效应”)时,可以排除催乳素瘤这一范例。此外,它强调了对无功能性垂体腺瘤患者进行全面、定期和终身监测以及密切监测血清PRL的重要性。